Vemika Chandra —BIO-PROTOCOL

Home About Us

Archive

Alexandros Alexandratos National and Kapodistrian University of Athens
34 protocols

Alka Mehra Institute of Genomics and Integrative Biology
36 protocols

Emilie Battivelli Buck institute
5 protocols

Maria Nguyen Northwestern University
2 protocols

Reviewer

Vemika Chandra

Research associate, The Children's Hospital of Philadelphia

Research focus

Cancer biology
Hematopoiesis, leukemia, stem cells, cytokine receptor, signaling, Immunology, Infection, Mycobacterium tuberculosis

Reviewer merit
Editor merit

Education

Ph. D, Institute of Microbial Technology, 2014

Lab information

Wei Tong Lab
https://www.med.upenn.edu/apps/faculty/index.php/g20000320/p8146029

Publications

https://scholar.google.co.in/citations?user=QPVELN0AAAAJ&hl=en

4 Protocols reviewed

Flow Cytometry Measurement of Glucocerebrosidase Activity in Human Monocytes

Authors: Laura P. Hughes, Glenda M. Halliday and Nicolas Dzamko, date: 04/05/2020, view: 956, Q&A: 0

Glucocerebrosidase (GCase) is an important enzyme for the metabolism of glycolipids. GCase enzyme deficiency is implicated in human disease and the efficient measurement of GCase activity is important for evaluating the efficacy of therapeutics ...

More >

Cellular Retention Assay to Determine the Interaction Frequency of CD19-directed Chimeric Antigen Receptor (CAR) Engineered Cells against CD19⁺ Leukemic Cells

Authors: Marvin I. De los Santos and Samuel D. Bernal, date: 09/05/2019, view: 1300, Q&A: 0

Cancer recognition by chimeric antigen receptor T (CAR-T) cell is prerequisite for cancer killing to occur. Anomalies in the binding specificity of scFv in the CAR construct may prevent successful eradication of these cancer cells. In some cases, ...

More >

More protocols >